These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Restoring public trust in gene therapy. Kennedy EM J Biolaw Bus; 2001; 4(3):3-4. PubMed ID: 12962103 [No Abstract] [Full Text] [Related]
7. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578 [TBL] [Abstract][Full Text] [Related]
8. AAV vectors and cardiovascular disease: targeting TNF receptor in the heart: clue to way forward with AAV? Hajjar RJ; Zsebo K Gene Ther; 2007 Dec; 14(23):1611-2. PubMed ID: 17943145 [No Abstract] [Full Text] [Related]
9. Gene therapy--still a work in clinical and regulatory progress. Hohmann EL N Engl J Med; 2009 Jul; 361(2):193-5. PubMed ID: 19587346 [No Abstract] [Full Text] [Related]
11. More flexibility on reporting to federal agencies about injuries to research subjects. Maloney DM Hum Res Rep; 2002 Jan; 17(1):1-2. PubMed ID: 16270435 [No Abstract] [Full Text] [Related]
12. Researchers and regulators reflect on first gene therapy death. Hollon T Nat Med; 2000 Jan; 6(1):6. PubMed ID: 10613797 [No Abstract] [Full Text] [Related]
14. Cancer fears cast doubts on future of gene therapy. Check E Nature; 2003 Feb; 421(6924):678. PubMed ID: 12610583 [No Abstract] [Full Text] [Related]
15. Pioneering HIV treatment would use interference and gene therapy. Check E Nature; 2005 Sep; 437(7059):601. PubMed ID: 16193002 [No Abstract] [Full Text] [Related]
16. A tumultuous year for gene therapy. Verma IM Mol Ther; 2000 Nov; 2(5):415-6. PubMed ID: 11082313 [No Abstract] [Full Text] [Related]
18. Humility at the frontier. A comeuppance for genetic therapy. Cannon A US News World Rep; 1999 Dec; 127(24):60. PubMed ID: 10724815 [No Abstract] [Full Text] [Related]
19. Policy statement of the American Society of Gene Therapy on reporting of patient adverse events in gene therapy trials. Woo SL Mol Ther; 2000 Jan; 1(1):7-8. PubMed ID: 10933905 [No Abstract] [Full Text] [Related]